Anti-CD49B (GBR500 (Vatelizumab, TMC-2206))

Anti-CD49B [GBR500 (Vatelizumab, TMC-2206)], Monoclonal, IgG4-S228P, kappa, Host: Human
Artikelnummer
ABAAb04186-13.12
Verpackungseinheit
100 μg
Hersteller
Absolute Antibody

Verfügbarkeit: wird geladen...
Preis wird geladen...
CloneID: GBR500 (Vatelizumab, TMC-2206)

Antigen Long Description: The parental mouse antibody was generated by immunizing BALB/c mice with human fibrosarcoma HT1080 cells. The original humanized version was generated by grafting the CDRs of murine parental antibody onto human acceptor framework regions.

Buffer Composition: PBS with 0.02% Proclin 300.

Concentration: 1 mg/ml

Available Custom Conjugation Options: AP, HRP, Fluorescein, APC, PE, Biotin Type A, Biotin Type B, Streptavidin, FluoroProbes 647H, Atto488, APC/Cy7, PE/Cy7

Uniprot Accession No.: P17301
Mehr Informationen
Artikelnummer ABAAb04186-13.12
Hersteller Absolute Antibody
Hersteller Artikelnummer Ab04186-13.12
Verpackungseinheit 100 μg
Mengeneinheit STK
Reaktivität Human, Rat (Rattus), Cynomolgus Monkey (Primate), Rhesus Monkey (Primate)
Klonalität Monoclonal
Methode ELISA, Flow Cytometry, Blocking, Therapeutic
Isotyp IgG4-S228P
Wirt Human
Produktinformation (PDF) Download
MSDS (PDF) Download